FDA Drug Safety Communication: Possible Risks of Pain Medicine Use During Pregnancy Reviewed

In reponse to concerns arising from recent reports questioning the safety of prescription and over-the-counter (OTC) pain medicines when used during pregnancy, the U.S. Food and Drug Administration evaluated research studies published in the medical literature and determined they are too limited to make any recommendations based on these studies at this time.  Because of this uncertainty, the use of pain medicines during pregnancy should be carefully considered.  Pregnant women are urged to discuss all medicines with their health care professionals before using them.  For a full report, please click HERE.

Additional information about acetaminophen use during pregnancy is available on the Teratology Society's Blog Post: "Member Experts Share Acetaminophen Answers."

Recent Stories
Structural Birth Defects Trainee Symposium to be hosted by the Society for Developmental Biology

Register Today for the Virtual Human Teratogens Course, November 2-4, 2021

Press Release: FASEB Launches Data-sharing and Reuse Initiative